SkinHealth Systems Inc.
SKIN
NASDAQ·Healthcare·Medical - Specialties·Mkt cap $88.8M
$0.69
▼ -1.72%
P/E
-3.04
Mkt Cap
$88.8M
52-Wk Range
$0.55–$2.69
52-Week Range
$0.55 - $2.69
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 70.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary HydraFacial technology with strong brand recognition and market leadership
- Recurring revenue model through consumable serums and treatment solutions
- Integrated digital ecosystem connecting providers and consumers for personalized experiences
- Expanding product portfolio addressing multiple beauty and wellness categories
- Global distribution network and established relationships with aesthetic practitioners
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising consumer demand for non-invasive aesthetic treatments and professional skincare
Value
Deep value opportunity - significant discount to Household Products peers
Momentum
Strong
+8.0% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying SKIN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of -$0.02 vs -$0.03 consensus (+20.0% surprise). Revenue of $72.1M vs $74.5M expected (-3.2%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+20.0%
Revenue trend · last 8Q
—
-14%
-15%
-14%
-10%
-1%
-7%
-8%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$78.8M
$83.5M
$69.6M
$78.2M
$70.7M
$82.4M
$64.9M
$72.1M
Margins · last 8Q
Gross
68.4%
Operating
5.0%
Profit
-3.7%
Wall Street consensus
3 analysts · 33% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
33%
Hold
67%
Sell
0%
Median Price Target
—
Latest: Roth Capital · $2.00 · May 20, 2026
vs Industry
How SKIN stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related